Eschweiler, Germany

Peter Jansen, Deceased

This inventor holds 2 USPTO granted patents. Top assignee: Gruenenthal Gmbh. Active years: 1998.


% Patents Active = 100.0

Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Peter Jansen: A Legacy in Pharmaceutical Innovation

Introduction

Peter Jansen was a notable inventor in the field of pharmaceuticals, known for his contributions to pain management drugs. He was based in Eschweiler, Germany, and held a total of 2 patents during his career. His work has had a lasting impact on the development of effective pain relief medications.

Latest Patents

Jansen's latest patents include a method of preparing the enantiomers of O-dimethyltramadol, which describes the preparation of these enantiomers and their use as pain-killing drugs. Additionally, he developed a method for separating the racemate of tramadol, which is crucial for enhancing the efficacy of this widely used pain medication.

Career Highlights

Throughout his career, Jansen worked with Gruenenthal GmbH, a company renowned for its focus on pain management solutions. His innovative approaches to drug formulation and separation techniques have contributed significantly to the pharmaceutical industry.

Collaborations

Jansen collaborated with several esteemed colleagues, including Helmut Heinrich Buschmann and Werner Winter. Their combined expertise helped advance the research and development of new pharmaceutical products.

Conclusion

Peter Jansen's contributions to the field of pharmaceuticals, particularly in pain management, have left a significant mark on the industry. His innovative patents continue to influence the development of effective pain relief medications today.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…